NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) Dividend History

NeuroSense Therapeutics Ltd. is a biotechnology company focused on developing therapeutics for neurodegenerative diseases, including Alzheimer's and Parkinson's. The company leverages its proprietary platform to identify and advance drugs aimed at addressing the underlying causes of these disorders. Founded to translate scientific discoveries into innovative treatments, NeuroSense aims to improve patient outcomes through targeted neuroprotective and disease-modifying therapies.

Dividend History

NeuroSense Therapeutics Ltd. Ordinary Shares currently does not pay dividends

Company News

  • The article discusses four biotech companies leveraging AI and machine learning technology to improve drug discovery and development processes. These companies are Absci, Firefly Neuroscience, Korro Bio, and NeuroSense Therapeutics.

    Investing.com
    Featured Companies: ABSI AIFF KRRO
  • Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. AeroVironment posted adjusted earnings of 97 cents per shares, beating analysts’ estimates of 62 cents per share. The company’s revenue came in at $180.8 million beating estimates of $170.908 million. AeroVironment shares dipped 9.2% to $128.42 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares jumped 113.4% to $4.63 after the company announced the DSMB overseeing its PRIME study recommended stopping enrollment due to efficacy. MicroAlgo Inc. (NASDAQ: MLGO) gained 61.2% to $3.90 after the company announced it plans to establish a postgraduate training practice base. Phio Pharmaceuticals Corp. (NASDAQ: PHIO) shares climbed 37.5% to $1.54. Lion Group Holding Ltd. (NASDAQ: LGHL) gained 37% to $1.30 following H1 results. Leju Holdings Limited (NYSE: LEJU) gained 37% to $1.8362. Pharvaris N.V. (NASDAQ: PHVS) shares climbed 33.7% to $28.00 after the company announced the CHAPTER-1 Phase 2 clinical study met its primary endpoint. Greenbrook TMS Inc. (NASDAQ: GBNH) shares gained 32.6% to $0.3048 after the company announced it raised $2.5 million in debt financing. Webuy Global Ltd (NASDAQ: WBUY) jumped 32.4% to $7.88 after the company announced it entered into a non-binding MOU to acquire controlling interest in PT. Tiga Sakti Utama. Chanson International Holding (NASDAQ: CHSN) climbed 28.2% to $6.10. Cano Health, Inc. (NYSE: CANO) climbed 28% to $12.11. Phreesia, Inc. (NYSE: PHR) gained 23.5% to $18.23 following third-quarter results. Reliance Global Group, Inc. (NASDAQ: RELI) rose 22.7% to $0.9679. Clean Earth Acquisitions Corp. (NASDAQ: CLIN) shares gained 22.6% to $7.53 after falling over 3% on Tuesday. Arvinas, Inc. (NYSE: ...

    Benzinga
  • U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28% to 14,270.30. The S&P 500 also rose, gaining, 0.32% to 4,581.88. Check This Out: Top 3 Materials Stocks That Are Set To Fly In Q4   Leading and Lagging Sectors   Industrials shares rose by 0.8% on Wednesday. In trading on Wednesday, energy shares fell by 0.6%.   Top Headline   U.S. private businesses hired 103,000 workers in November compared to a revised 106,000 gain in October and versus markets expectations of 130,000.   Equities Trading UP   Sera Prognostics, Inc. (NASDAQ: SERA) shares shot up 144% to $5.30 after the company announced the DSMB overseeing its PRIME study recommended stopping enrollment due to efficacy. Shares of MicroAlgo Inc. (NASDAQ: MLGO) got a boost, shooting 62% to $3.9150 after the company announced it plans to establish a postgraduate training practice base. Pharvaris N.V. (NASDAQ: PHVS) shares were also up, gaining 33% to $27.84 after the company announced the CHAPTER-1 Phase 2 clinical study met its primary endpoint.   Equities Trading DOWN   ImmunoPrecise Antibodies Ltd. (NASDAQ:

    Benzinga
    Featured Companies: IPA MLGO PHVS SERA
  • Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook. SentinelOne reported third-quarter revenue of $164.2 million, beating the analyst consensus estimate of $156.09 million. The company also reported an adjusted loss of 3 cents per share, beating the analyst consensus estimate of a loss of 8 cents per share, according to Benzinga Pro. The company raised the full-year 2024 revenue outlook from $605 million to $616 million. SentinelOne shares gained 18.6% to $23.71 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Clean Earth Acquisitions Corp. (NASDAQ: CLIN) shares gained 105.5% to $12.64 in pre-market trading after falling over 3% on Tuesday. Greenbrook TMS Inc. (NASDAQ: GBNH) shares rose 78.7% to $0.4109 in pre-market trading after the company announced it raised $2.5 million in debt financing. Dune Acquisition Corporation (NASDAQ: DUNE) rose 23.8% to $6.08 in pre-market trading after dipping over 15% on Tuesday. Bit Brother Limited (NASDAQ: BETS) gained 23.5% to $0.0414 in pre-market trading. Bit Brother shares fell ...

    Benzinga
    Featured Companies: ABTS ACRS ALLR ASAN ASPN BOX IPA PHIO S WNW YEXT
  • Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. Daktronics posted quarterly earnings of 5 cents per share, missing market estimates of 13 cents per share. The company’s quarterly sales came in at $199.37 million versus expectations of $213.70 million, according to Benzinga Pro. Daktronics shares declined 10.7% to $9.15 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Meiwu Technology Company Limited (NASDAQ: WNW) shares climbed 80.6% to $0.13. Volato Group, Inc. (NYSE: SOAR) shares gained 72% to $15.13. Clearmind Medicine Inc. (NASDAQ: CMND) jumped 62.6% to $6.23 after the company announced results in its cocaine addiction treatment. Allarity Therapeutics, Inc. (NASDAQ: ALLR) climbed 46.9% to $0.8946 after the company announced initial results from its ongoing Phase 2 clinical trial evaluating the efficacy of stenoparib in women with advanced ovarian cancer. Nxu, Inc. (NASDAQ: NXU) gained 30% to $0.0361 after gaining 29% on Monday. NXU named Sarah Wyant as interim CFO, succeeding Apoorv Dwivedi. XBP Europe Holdings, Inc. (NASDAQ: XBP) surged 24.7% to $47.40. Travere Therapeutics, Inc. (NASDAQ: TVTX) gained 24% to $7.80. Travere completed successful pre-NDA meeting for FILSPARI in IgAN. Citigroup upgraded Travere Therapeutics from Neutral to Buy and raised the price target from $7 to $10. Harbor Custom Development, Inc. (NASDAQ: HCDI) climbed 19.4% to $1.29. Mercurity Fintech Holding Inc. (NASDAQ: MFH) surged 17% to $1.3806. Mercurity Fintech announced a $6 million private placement financing. Heart Test Laboratories, Inc. (NASDAQ: HSCS) ...

    Benzinga
Dividend data last updated 06/07/2025 04:22:31 UTC